Systematic review of levodopa dose equivalency reporting in Parkinson's disease
CL Tomlinson, R Stowe, S Patel, C Rick… - Movement …, 2010 - Wiley Online Library
Abstract Interpretation of clinical trials comparing different drug regimens for Parkinson's
disease (PD) is complicated by the different dose intensities used: higher doses of levodopa …
disease (PD) is complicated by the different dose intensities used: higher doses of levodopa …
Parkinson's disease
A Samii, JG Nutt, BR Ransom - The Lancet, 2004 - thelancet.com
Parkinson's disease is the most common serious movement disorder in the world, affecting
about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons …
about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons …
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation
Objective To assess the 10-year motor outcome of deep brain stimulation of the subthalamic
nucleus (STN-DBS) in patients with Parkinson disease (PD). Design Patients with PD with …
nucleus (STN-DBS) in patients with Parkinson disease (PD). Design Patients with PD with …
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
Deep brain stimulation of the subthalamic nucleus represents the most important innovation
for treatment of advanced Parkinson's disease. Prospective studies have shown that …
for treatment of advanced Parkinson's disease. Prospective studies have shown that …
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease
Gait disturbances and akinesia are extremely disabling in advanced Parkinson's disease. It
has been suggested that modulation of the activity of the pedunculopontine nucleus (PPN) …
has been suggested that modulation of the activity of the pedunculopontine nucleus (PPN) …
The impact on Parkinson's disease of electrical parameter settings in STN stimulation
Background: The main advantage of deep brain stimulation (DBS) in the treatment of PD is
that the electrical settings can be adjusted to optimize benefits and minimize adverse effects …
that the electrical settings can be adjusted to optimize benefits and minimize adverse effects …
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease
A Funkiewiez, C Ardouin, E Caputo, P Krack… - Journal of Neurology …, 2004 - jnnp.bmj.com
Background: Long term effects of subthalamic nucleus (STN) stimulation on cognition, mood,
and behaviour are unknown. Objective: This study evaluated the cognitive, mood, and …
and behaviour are unknown. Objective: This study evaluated the cognitive, mood, and …
Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis
Background Deep brain stimulation of the subthalamic nucleus (STN DBS) is an
increasingly common treatment for Parkinson's disease. Qualitative reviews have concluded …
increasingly common treatment for Parkinson's disease. Qualitative reviews have concluded …
Implantation of deep brain stimulators into subthalmic nucleus: technical approach and magnetic imaging—verified electrode locations
Object. Chronic deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a
procedure that is rapidly gaining acceptance for the treatment of symptoms in patients with …
procedure that is rapidly gaining acceptance for the treatment of symptoms in patients with …
The functional role of the subthalamic nucleus in cognitive and limbic circuits
Once it was believed that the subthalamic nucleus (STN) was no more than a relay station
serving as a “gate” for ascending basal ganglia-thalamocortical circuits. Nowadays, the STN …
serving as a “gate” for ascending basal ganglia-thalamocortical circuits. Nowadays, the STN …